Petros Galanakis

[Petros Galanakis @pgalanak]

http://t.co/sojHkY97kq http://t.co/Dhys07KODp

[Scientific American @sciam]

How We Learn http://t.co/18Wt79Kka1

[CNN Business @CNNBusiness]

Average cost to raise a kid is $241,080 and climbing - and that doesn't even include college! http://t.co/jaHpXJCRHM

[News from Science @NewsfromScience]

New discovery reveals Neandertals weren't just copycats, came up with own clever ideas http://t.co/wpURW3ZWMU

[Petros Galanakis @pgalanak]

16 Bookstores You Have To See Before You Die http://t.co/9BqZ4C8ohA

[The Booker Prizes @TheBookerPrizes]

We're glad! RT @EleanorFitz This made me smile :) “@ManBookerPrize: Here it is... The 2013 #ManBookerPrize longlist! http://t.co/UDNmVOtIPy”

[Miguel Tovar @blogaceutics]

If I Were A Big Pharma Head Of R&D... - Forbes http://t.co/1kersCZ3u1

[Nature Reviews Genetics @NatureRevGenet]

And a Research Highlight on an example of structure and function for a lncRNA http://t.co/joDq3ciiVK

[Nature Reviews Genetics @NatureRevGenet]

Analysis from #diseasemechanisms series: pathways and complex relationships among immune-mediated diseases http://t.co/oqR5kz5zrD

[Nature Reviews Drug Discovery @NatRevDrugDisc]

What are the key factors for academic laboratories to successfully interact with CROs in early-stage drug discovery? http://t.co/FFaqtL1pnk

[Petros Galanakis @pgalanak]

p53 restoration of function drug candidate: an interview with Dr.... http://t.co/Rv5wRbiuKr

[Petros Galanakis @pgalanak]

AstraZeneca arthritis drug has mixed results in Phase III trial http://t.co/14ocPTAqUg

[Nature Medicine @NatureMedicine]

74 new susceptibility genes found for breast, ovarian and prostate cancer http://t.co/eX6MKgXKp8

[NatureRevClinOncol @NatRevClinOncol]

New research highlight: We're closer to drugging p53 (£) http://t.co/u4TQIGU0UM

[Nature Biotechnology @NatureBiotech]

Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis http://t.co/Znil5kix

[News from Science @NewsfromScience]

Misconduct, not mistakes, account for more than 2/3rds of scientific retractions http://t.co/5s9ZYqYN #Insider

[Nature Portfolio @NaturePortfolio]

Structure-based prediction of protein–protein interactions on a genome-wide scale: http://t.co/NHZBphTS

[Harvard Business Review @HarvardBiz]

Bad data is worse than no data at all. http://t.co/Ce81gau4

[Petros Galanakis @pgalanak]

Πρόταση 3.0, του Γιάνη Βαρουφάκη (@yanisvaroufakis) via @protagongr http://t.co/CVzhheQs via @sharethis

[The Lancet @TheLancet]

Stem cell researchers in the USA and abroad are reeling from new laws in Texas that may impede clinical research http://t.co/djiAmY2i